[
    [
        {
            "time": "2018-01-09",
            "original_text": "【医药-恒瑞医药(600276)】江琦：BTK抑制剂授权海外，创新药国际化再下一城-20180109",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "BTK抑制剂",
                    "授权海外",
                    "创新药",
                    "国际化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 10,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-01-09",
            "original_text": "【晨会聚焦】创新药龙头的投资机会如何？",
            "features": {
                "keywords": [
                    "创新药",
                    "龙头",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        }
    ]
]